Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS (AVNR), bought 11,900 shares at $0.44 ($5K) on 2009-02-24, disclosed to the SEC on 2009-02-25.
Open-market purchase of $5k AVNR by Vice President, Finance. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.42 | 1,000 | $420 | 8.1% |
| 2 | $0.44 | 10,900 | $5K | 91.9% |
| Total | $0.44 avg | 11,900 | $5K | 100% |
| Filing → |
| AVNR | SELL | 2014-10-24 | $25K | — | Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |